Stockreport

ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens

ZIVO BIOSCIENCE INC  (ZIVO) 
NASDAQ:AMEX Investor Relations: zivobioscience.com
PDF BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--ZIVO Bioscience, Inc. (OTCQB: ZIVO), a pioneering biotech/agtech R&D company dedicated to developing therapeutic, medicinal [Read more]